Stock IKT INHIBIKASE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Inhibikase Therapeutics, Inc.

Equities

IKT

US45719W2052

Market Closed - Nasdaq
Other stock markets
 01:30:00 2024-07-03 pm EDT 		5-day change 1st Jan Change
1.15 USD -4.92% Intraday chart for Inhibikase Therapeutics, Inc. -16.02% -9.41%
Jun. 17 Inhibikase Therapeutics Completes Enrollment of the Phase 2 ?201? Trial Evaluating Risvodetinib in Untreated Parkinson?s Disease CI
Jun. 05 Inhibikase Therapeutics, Inc. Announces Expansion to Its Therapeutic Pipeline CI
2d175d2bc86cb94f0ce55f7953fa.e7xs6fvzFqZO79HPMBCkYoaKpQSYrlZHl3kR7_YXzTw.PI5bvLLKWtYdsJa9AlviDc78wjfdwi51z08lqLN5nEw00yWomp9V0Te-nA~4bed5393c1d39b01dbb630430919f030
  1. Stock Market
  2. Equities
  3. IKT Stock
  4. Charts Inhibikase Therapeutics, Inc.
  5. News Chart